scholarly journals Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study

Drugs in R&D ◽  
2018 ◽  
Vol 18 (2) ◽  
pp. 163-163
Author(s):  
Sebastiano Buti ◽  
Maddalena Donini ◽  
Melissa Bersanelli ◽  
Alessia Gattara ◽  
Francesco Leonardi ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Retrospective Study ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Safety And Efficacy ◽  
Alternative Schedule

scholarly journals Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study

Drugs in R&D ◽  
2017 ◽  
Vol 17 (4) ◽  
pp. 585-596 ◽  
Author(s):  
Sebastiano Buti ◽  
Maddalena Donini ◽  
Melissa Bersanelli ◽  
Alessia Gattara ◽  
Francesco Leonardi ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Retrospective Study ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Safety And Efficacy ◽  
Alternative Schedule

Safety and Efficacy of Sunitinib in Patients from Italy with Metastatic Renal Cell Carcinoma: Final Results from an Expanded-Access Trial

Oncology ◽  
2015 ◽  
Vol 88 (5) ◽  
pp. 273-280 ◽  
Author(s):  
Cora N. Sternberg ◽  
Fabio Calabr� ◽  
Sergio Bracarda ◽  
Giacomo Carten� ◽  
Giovanni Lo Re ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Safety And Efficacy ◽  
Expanded Access

scholarly journals Safety and efficacy of sunitinib in patients from Latin America: subanalysis of an expanded access trial in metastatic renal cell carcinoma

2016 ◽  
Vol Volume 9 ◽  
pp. 5839-5845 ◽  
Author(s):  
Jaya Vas ◽  
Carlos Barrios ◽  
Daniel Herchenhorn ◽  
Matias Chacón ◽  
Paula Cabrera-Galeana ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Latin America ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Safety And Efficacy ◽  
Expanded Access

Efficacy and safety of first‐line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study

2020 ◽  
Vol 27 (12) ◽  
pp. 1095-1100 ◽  
Author(s):  
Toshikazu Tanaka ◽  
Shingo Hatakeyama ◽  
Kazuyuki Numakura ◽  
Koichi Kido ◽  
Daisuke Noro ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Retrospective Study ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Efficacy And Safety ◽  
First Line
Sign in / Sign up

Export Citation Format

Share Document